Press Release

Parkinson’s Disease Drugs Market Analysis 2020 Global Industry Analysis To 2026

Parkinson’s Disease Drugs Market Analysis 2020 Global Industry Analysis To 2026

Parkinson’s Disease Drugs Market Size, Share, Growth, Business Analysis, and Regional Forecast to 2026 is latest research report on Global Parkinson’s Disease Drugs Market published by “Fortune Business Insights”. According to report the Global Parkinson’s Disease Drugs Market to grow at 8.1% CAGR and reach $8,383.2 million value by 2026. Parkinson’s Disease Drugs Industry report anlayzes Market for Parkinson’s Disease Drugs by Drug Class (Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors), Route of Administration (Oral, Injection, Transdermal), Distribution Channels (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) & Regional Forecast, 2019 – 2026.

Parkinson’s Disease Drugs Industry Key Players Analyzed in Report Are:

Merck & Co, Pfizer, Teva Pharmaceutical Industries Ltd, Vertical Pharmaceuticals, Orion Pharma, ACADIA Pharmaceuticals, H. Lundbeck A/S, and Impax Laboratories.

Global Parkinson’s Disease Drugs Market Insights:

The global Parkinson’s Disease Drugs market size is predicted to grow $8,383.2 million by 2026, exhibiting a CAGR of 8.1% during the forecast period. Parkinson’s disease (PD) is the central nervous system disorder that affects body movement, uncontrollable shaking and tremors, difficulties in balance.

Parkinson’s is a neurodegenerative disease which primarily affects the human brain parts, making it difficult for the person to function or perform daily routine. People suffering from Parkinson’s cannot produce enough dopamine, which leads to stiffness, tremors, walking problems among others. This disease can become severe if not treated on time. This severity can result in increasing demand for Parkinson’s disease treatment.

As per Parkinson’s Disease Foundation, around 10 million people across the world are suffering from Parkinson’s disorder. According to Medical New Today, aggression can be toxic to Parkinson’s patients. Consequently, researchers at Purdue University have found that a protein called HYPE can reduce this aggression and help patients to fight this disease. As per the report, the global Parkinson’s disease drugs market was valued at US$ 4,500.0 Mn and is anticipated to be worth US$ 8,383.2 Mn by 2026. The global market for Parkinson’s disease drugs market is expected to rise at a healthy CAGR of 8.1% between 2018 and 2026.

As per recent research studies, around 1.2 million people in Europe and 1 million in the U.S. have Parkinson. Considering this, the sales of Parkinson’s disease drugs is likely to increase, which will drive the global Parkinson’s diseases drugs market.

Parkinson’s Disease Drugs Market Segmentation:

The global Parkinson’s Disease Drugs Market is segmented on the basis of Drug Class, Route of Administration, Distribution Channels and Region.

Based on Drug Class the Global Parkinson’s Disease Drugs Market is segmented into Decarboxylase Inhibitors, Dopamine Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitors.

Based on Route of Administration the Parkinson’s Disease Drugs market is segmented by Oral, Injection, Transdermal.

Based on Distribution Channels Parkinson’s Disease Drugs market is segmented by Hospital Pharmacy, Retail Pharmacy, Online Pharmacy.

On the basis of region market for Parkinson’s Disease Drugs segmented by North America, Europe, Asia-Pacifica, Africa and other regions.

Regional Market Insights:

Report analyzes Global Market for Parkinson’s Disease Drugs by North America, South America, Asia-Pacific, Europe, Middle East and Africa.

Among regions, Europe witnesses the highest prevalence of Parkinson’s. As per the report, this region is expected to foresee considerable growth in the forecast years. In 2018, the market in Europe was worth US$ 1,540.7 Mn and the market grows with the rising support from governments.

On the other hand, the market in North America is anticipated to render the maximum share in the market during the forecast period. This is attributable to the rising spending on research and development (R&D) activities and FDA approvals on new pipeline drugs. Furthermore, Acorda Therapeutics Inc. launches an inhalation powder called INBRIJA in the U.S. in February 2019. This powder aims to help Parkinson’s patients and driven by this, the Parkinson’s disease drugs market share is likely to increase in North America. Improving distribution network among pharma companies is expected to drive the Parkinson’s disease market growth in Asia Pacific. The market in this region is likely to report higher CAGR owing to the rising demand for Parkinson’s disease drugs from India and China.

Highlights of the Report:

In-depth analysis of various insights, namely, Parkinson’s Disease Drugs Market trends, growth drivers, opportunities, and other related challenges.

Comprehensive details of key market players, their core competencies, and Parkinson’s Disease Drugs Market share.

The potency of suppliers and buyers to make better business decisions.

Lists out the market size in terms of volume.

Table of Content:


Research Scope

Market Segmentation

Research Methodology

Definitions and Assumptions

Executive Summary

Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Key Insights


Related Report:

More HealthCare related news at:

Eye Supplements Market Size

Personalized Medicine Market Report

Capnography Equipment Market 2020

Extra Corporeal Membrane Oxygenation (ECMO) Market Size

Hemodialysis Bloodline Systems Market Size

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

US: +1 424 253 0390

UK: +44 2071 939123

APAC: +91 744 740 1245

Email: [email protected]


Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *